Please login to the form below

Not currently logged in
Email:
Password:

Pegasus strengthens its Pharma and Life Sciences division

Appoints three new team members to join its Northern base

Pegasus, an Ashfield company, has appointed a trio of new team members to join its pharma and life sciences division based in Macclesfield, UK.

Kesha Tansey joins the team from within Ashfield as an account director, a role that will see her lead integrated communications programmes.

She is joined by newly appointed senior account executive Trystan George, who moves from The Scott Partnership and Bill Johnson, who arrived from Langland as an account executive.

Jo Spadaccino, board director and head of pharma and life sciences, Pegasus, said: “Our Macclesfield office was only launched in the spring, but our unique proposition is already attracting fantastic candidates from around the north-west.

“I’m really looking forward to working with Kesha, Trystan and Billy, along with our existing Macclesfield team members, who continue shaping the direction of our new hub.”

Earlier this year, Pegasus scooped an award for ‘Excellence In Integrated Product/Brand Communications at the 2017 Communiqué awards.

5th September 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...